GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Darya-Varia Laboratoria Tbk PT DVLA.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

1,570

0.00%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in IDR, from our data supplier.

FY2025

Revenue

IDR 2.23trn

FY2016FY2025

Net income

IDR 163.95bn

FY2016FY2025

Free cash flow

IDR 93.82bn

FY2016FY2025

Shareholders' equity

IDR 1.48trn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueIDR 2.23trnIDR 2.09trnIDR 1.89trnIDR 1.92trnIDR 1.90trnIDR 1.83trnIDR 1.81trnIDR 1.70trnIDR 1.58trnIDR 1.45trn
Gross profitIDR 1.17trnIDR 1.10trnIDR 975.24bnIDR 1.01trnIDR 995.77bnIDR 931.99bnIDR 973.48bnIDR 925.41bnIDR 893.96bnIDR 801.44bn
Research and development——IDR 30.66bnIDR 25.01bnIDR 40.30bnIDR 26.30bnIDR 23.67bnIDR 23.17bnIDR 24.16bn—
Operating incomeIDR 209.48bnIDR 206.40bnIDR 190.05bnIDR 198.35bnIDR 208.60bnIDR 210.72bnIDR 296.62bnIDR 267.31bnIDR 219.97bnIDR 203.63bn
Net incomeIDR 163.95bnIDR 156.15bnIDR 146.34bnIDR 149.38bnIDR 146.51bnIDR 162.07bnIDR 221.78bnIDR 200.65bnIDR 162.25bnIDR 152.08bn
Diluted earnings per share146.38139.42130.66133.37130.81144.71198.11179.79145.39136.28

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsIDR 2.35trnIDR 2.16trnIDR 2.04trnIDR 2.01trnIDR 2.09trnIDR 1.99trnIDR 1.83trnIDR 1.68trnIDR 1.64trnIDR 1.53trn
Cash and short-term investmentsIDR 341.56bnIDR 357.82bnIDR 240.04bnIDR 357.02bnIDR 583.30bnIDR 265.31bnIDR 339.05bnIDR 306.12bnIDR 450.88bnIDR 380.08bn
Total liabilitiesIDR 873.13bnIDR 712.57bnIDR 637.74bnIDR 605.52bnIDR 705.11bnIDR 660.42bnIDR 523.88bnIDR 482.56bnIDR 524.59bnIDR 451.79bn
DebtIDR 206.9mIDR 1.04bnIDR 1.47bnIDR 1.89bnIDR 22.98bnIDR 988.5m————
Shareholders' equityIDR 1.48trnIDR 1.45trnIDR 1.40trnIDR 1.40trnIDR 1.39trnIDR 1.33trnIDR 1.31trnIDR 1.20trnIDR 1.12trnIDR 1.08trn
Shares outstanding1,120m1,120m1,120m1,120m1,120m1,120m1,119m1,116m1,116m1,116m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsIDR 201.14bnIDR 331.76bnIDR 109.19bn−IDR 16.06bnIDR 435.33bnIDR 106.58bnIDR 272.54bnIDR 26.63bnIDR 230.74bnIDR 187.48bn
Capital spending−IDR 107.32bn−IDR 102.65bn−IDR 97.92bn−IDR 58.18bn−IDR 86.99bn−IDR 62.81bn−IDR 58.96bn−IDR 45.49bn−IDR 38.40bn−IDR 195.96bn
Free cash flowIDR 93.82bnIDR 229.11bnIDR 11.27bn−IDR 74.24bnIDR 348.34bnIDR 43.78bnIDR 213.58bn−IDR 18.86bnIDR 192.34bn−IDR 8.49bn
Dividends paid−IDR 120.96bn−IDR 120.96bn−IDR 135.52bn−IDR 129.92bn−IDR 125.44bn−IDR 119.84bn−IDR 119.62bn−IDR 119.41bn−IDR 111.59bn−IDR 39.06bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueIDR 613.80bnIDR 594.80bnIDR 603.56bnIDR 542.09bnIDR 541.81bnIDR 544.29bnIDR 494.94bnIDR 505.45bn
Gross profitIDR 296.95bnIDR 291.84bnIDR 315.24bnIDR 283.97bnIDR 284.44bnIDR 308.36bnIDR 259.17bnIDR 272.49bn
Operating incomeIDR 46.02bnIDR 72.34bn−IDR 3.33bnIDR 52.91bnIDR 58.21bnIDR 103.14bnIDR 11.72bnIDR 39.61bn
Net incomeIDR 38.41bnIDR 55.31bn−IDR 383.3mIDR 42.89bnIDR 42.57bnIDR 78.87bnIDR 8.76bnIDR 28.03bn
Diluted earnings per share34.2949.38-0.3438.3038.0170.427.8225.03
Cash from operationsIDR 32.05bnIDR 143.99bnIDR 9.35bnIDR 37.23bnIDR 94.03bnIDR 60.55bn−IDR 4.82bnIDR 256.51bn
Capital spending−IDR 28.77bn−IDR 19.48bn−IDR 32.50bn−IDR 26.49bn−IDR 26.36bn−IDR 21.97bn−IDR 29.50bn−IDR 26.03bn
Free cash flowIDR 3.28bnIDR 124.50bn−IDR 23.15bnIDR 10.73bnIDR 67.67bnIDR 38.58bn−IDR 34.32bnIDR 230.48bn
Total assetsIDR 2.61trnIDR 2.52trnIDR 2.35trnIDR 2.39trnIDR 2.40trnIDR 2.39trnIDR 2.16trnIDR 2.25trn
Cash and short-term investmentsIDR 471.02bnIDR 467.06bnIDR 341.56bnIDR 407.53bnIDR 469.47bnIDR 398.87bnIDR 357.82bnIDR 437.95bn
DebtIDR 119.4mIDR 163.3mIDR 206.9mIDR 709.4mIDR 822.0mIDR 933.4mIDR 1.04bnIDR 1.15bn
Shareholders' equityIDR 1.50trnIDR 1.53trnIDR 1.48trnIDR 1.53trnIDR 1.49trnIDR 1.53trnIDR 1.45trnIDR 1.48trn

Financial ratios

Data as of 27 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin52.6%52.5%51.6%52.5%52.4%50.9%——
Operating margin9.4%9.9%10.1%10.3%11.0%11.5%——
Net margin7.3%7.5%7.7%7.8%7.7%8.9%——
Return on equity11.1%10.8%10.4%10.6%10.5%12.2%——
Return on assets7.0%7.2%7.2%7.4%7.0%8.2%——
Free cash flow yield17.4%24.5%11.7%2.4%29.5%9.6%——
Revenue growth6.9%10.4%-1.4%0.8%3.9%0.9%——
Earnings growth5.0%6.7%-2.0%2.0%-9.6%-26.9%——
Current ratio2.45x2.69x2.86x3.00x2.57x2.52x——
Debt to equity0.00x0.00x0.00x0.00x0.02x0.00x——
Equity ratio62.9%67.0%68.8%69.9%66.7%66.8%——
Interest coverage648.94x591.50x498.27x392.24x416.56x492.76x——
R&D as a share of sales——1.6%1.3%2.1%1.4%1.3%1.4%
Buybacks as a share of market value0.0%0.0%0.0%0.0%0.0%-0.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.2%4.1%5.5%
Operating income1.8%-0.1%5.2%
Net income3.2%0.2%4.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin52.6%52.3%52.1%53.0%
Operating margin9.6%9.9%10.3%11.9%
Net margin7.4%7.6%7.8%9.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings11.311.512.717.821.016.711.410.813.512.9
Price to sales0.80.91.01.41.61.51.41.31.41.4

Dividends and splits

Per share, in the currency the company pays

Paid for 18 years. Last went ex-dividend on 30 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year64.00108.00108.00121.00116.00112.00107.00107.00
  • 2-for-1 split · 12 Nov 2010
  • 2-for-1 split · 12 Oct 1995
  • 2-for-1 split · 28 Sept 1995

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.